HSR25-186: A Systematic Review and Meta-Analysis of Randomized Controlled Trials to Evaluate the Risk of General Systemic Adverse Events in Locally Advanced Head and Neck Squamous Cell Carcinoma Treated With Immune Checkpoint Inhibitors
Roles
Author
Document Type
Article
Publication Date
1-1-2025
Publication Title
Journal of the National Comprehensive Cancer Network
DOI
10.6004/jnccn.2024.7329
Recommended Citation
Khalid, T., Aboaid, H., Jones, D. T., Ta, J., Srinvasmurthy, R., Do, K., Nguyen, K., Fama, K., Nanda, R. K., Aamer, S., Bigcas, J. L., & Thein, K. Z. (2025). HSR25-186: A Systematic Review and Meta-Analysis of Randomized Controlled Trials to Evaluate the Risk of General Systemic Adverse Events in Locally Advanced Head and Neck Squamous Cell Carcinoma Treated With Immune Checkpoint Inhibitors. Journal of the National Comprehensive Cancer Network, 23 (3.5), Article HSR25-186. https://doi.org/10.6004/jnccn.2024.7329
